|
|
Volumn 63, Issue 13, 2014, Pages 1340-1341
|
|
Intracoronary versus intravenous abciximab bolus administration
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
FOLLOW UP;
HEART LEFT VENTRICLE EJECTION FRACTION;
HIGH RISK PATIENT;
HUMAN;
INCIDENCE;
LETTER;
LOW RISK POPULATION;
META ANALYSIS (TOPIC);
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SAMPLING;
ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
STUDY DESIGN;
CLINICAL EFFECTIVENESS;
DRUG ACTIVITY;
HEART DISEASE;
HEART INFARCTION SIZE;
INTRACORONARY DRUG ADMINISTRATION;
LOW RISK PATIENT;
RISK BENEFIT ANALYSIS;
CARDIAC SURGICAL PROCEDURES;
CAROTID STENOSIS;
CORONARY DISEASE;
ENDARTERECTOMY, CAROTID;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
PREOPERATIVE CARE;
|
|
EID: 84897440991
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2013.08.1662 Document Type: Letter |
|
Times cited : (4)
|
|
References (5)
|
